Hoffmann-La Roche Inc successfully recovered the domain rochediagnosticus.com from respondent he jxing. The panel ruled in favor of transfer after finding that the domain, which mimicked the company’s diagnostic branding, was registered and used in bad faith.
Case Snapshot
| Case Number | D2026-3153 |
|---|---|
| Complainant | Hoffmann-La Roche Inc |
| Respondent | he jxing |
| Disputed Domain | rochediagnosticus.com |
| Threat Tactic | Corporate Impersonation |
| Decision Date | 2026-09-11 |
| Panelist | Yuri Chumak |
| Outcome | Transfer |
| Official Source | https://www.wipo.int/amc/en/domains/search/text.jsp?case=D2026-3153 |
Facing Unauthorized Domain Registrations or Brand Abuse?
Our domain dispute attorneys represent trademark owners and businesses worldwide before WIPO, Forum (NAF), and CAC. Explore our Domain Name Disputes and Enforcement & Takedowns services, or request a free case evaluation.
Request Case EvaluationBusiness Risk Assessment: Impersonation and Traffic Diversion
The registration of ‘rochediagnosticus.com’ on May 6, 2026, represents a direct threat to consumer trust and brand integrity by employing corporate impersonation. The respondent actively utilized the ROCHE trademark to mirror the appearance of an official diagnostic platform, a tactic designed to exploit the reputation of Hoffmann-La Roche Inc. for unauthorized commercial gain. By creating this false impression of affiliation, the respondent risked diverting unsuspecting users—who may be seeking legitimate diagnostic products or services—to an illegitimate interface, thereby jeopardizing the complainant’s established customer relationships and brand consistency.
This case underscores the tactical use of privacy services to complicate enforcement, as the registrant identity initially disclosed by the registrar differed from the actual bad-faith actor. Such obfuscation, combined with the deliberate targeting of the ‘ROCHE’ mark, forced the brand owner to undergo a 76-day UDRP resolution process to reclaim control over its digital presence. The reliance on domain-based impersonation as a deceptive tool highlights the ongoing operational overhead required to mitigate unauthorized commercial activity that exploits known intellectual property, even when the respondent ultimately defaults in legal proceedings.
Panel Reasoning: Evaluating Trademark Misappropriation and Bad Faith
The panel determined that the disputed domain name, ‘rochediagnosticus.com’, is confusingly similar to the Complainant’s ROCHE trademark. By incorporating the trademark in its entirety and appending ‘diagnostic’ and ‘us’, the Respondent created a misleading association with the Complainant’s established diagnostic business. Under the UDRP, such modifications do not negate identity but rather enhance the likelihood of consumer confusion, as the domain implies a specific geographic or operational link to the Complainant’s legitimate U.S. operations.
Regarding the second element of the policy, the panel found the Respondent lacked rights or legitimate interests in the domain. The evidence confirmed that the Respondent is neither affiliated with nor authorized by Hoffmann-La Roche Inc. and is not commonly known by the name. Furthermore, the use of the domain to host a website that actively mimicked the Complainant’s diagnostic services failed to satisfy the requirements for a bona fide offering of goods or services or a legitimate noncommercial or fair use.
Finally, the panel concluded that the domain was registered and used in bad faith, noting that the Complainant’s trademark rights date back to 1986, long preceding the May 2026 registration. The Respondent’s decision to display the ROCHE mark on a site that clearly targeted the Complainant’s brand demonstrates a deliberate intent to solicit internet traffic for commercial gain. By creating a false impression of corporate affiliation, the Respondent sought to monetize the Complainant’s reputation, a behavior the panel correctly identified as a primary indicator of bad faith under the policy.
Strategic Enforcement Against Corporate Impersonation
The Complainant successfully recovered the domain rochediagnosticus.com by demonstrating that the Respondent used the ROCHE mark to create a deceptive association with the brand’s actual diagnostic services. By incorporating the trademark in its entirety and appending descriptive terms like ‘diagnostic’ and ‘us,’ the Respondent engaged in a clear strategy of impersonation designed to mislead consumers. The Complainant’s evidence was bolstered by presenting extensive documentation of its long-standing trademark rights, which date back to 1986, effectively proving that the Respondent’s registration was a calculated attempt to capitalize on the ROCHE brand’s established market reputation.
The persuasiveness of the case relied on the clear nexus between the domain’s structure and its active content, which explicitly mimicked the Complainant’s official diagnostic offerings. Despite the Respondent’s attempt to obfuscate ownership through privacy services, the Complainant utilized the Registrar’s verification process to secure the underlying identity data, thereby streamlining the procedural history. The Respondent’s failure to submit a response further confirmed the Panel’s finding of bad faith registration and use. This outcome reinforces the effectiveness of proactive monitoring for domain names that pair core brand assets with industry-specific keywords, even when the registrant utilizes anonymity protections.
Practical Recommendations
- Monitor new domain registrations for strings combining your primary trademark with industry-specific suffixes (e.g., ‘diagnostic’, ‘med’) to proactively identify typosquatting or impersonation risks.
- Utilize professional domain monitoring tools to capture ‘point-in-time’ screenshots of suspicious sites immediately upon discovery, as website content can be changed or taken down to evade UDRP evidence requirements.
- Include registrar verification requests in your early enforcement workflow to pierce privacy shield masks early, ensuring accurate identification of the underlying respondent for UDRP proceedings.
- Prioritize UDRP filings for domains displaying counterfeit branding, as evidence of actual commercial intent and unauthorized mark display significantly lowers the burden of proving bad faith.
- Standardize an internal evidence package that includes trademark registration records, examples of authorized versus unauthorized site designs, and a clear timeline of the disputed domain’s active use.
Frequently Asked Questions (FAQ)
Why was the domain ‘rochediagnosticus.com’ considered confusingly similar to the ROCHE trademark?
The panel found the domain confusingly similar because it incorporated the well-known ROCHE mark in its entirety. The inclusion of ‘diagnostic’ and ‘us’ did not mitigate this; rather, it reinforced a deceptive association with the Complainant’s actual diagnostic business operations.
What evidence established the Respondent’s lack of rights or legitimate interests?
The Respondent was neither affiliated with nor authorized by Hoffmann-La Roche Inc. to use the ROCHE mark. The panel noted that using the domain to host a website posing as an official Roche diagnostic service does not qualify as a bona fide offering of goods or services or a legitimate noncommercial use.
How did the panel determine the domain was registered and used in bad faith?
Bad faith was demonstrated by the fact that the Complainant’s trademark rights long predated the May 6, 2026, registration. The Respondent clearly targeted the ROCHE mark to create a false impression of affiliation for commercial gain, further evidenced by their failure to provide any defense during the proceedings.
What was the tactical outcome of this UDRP case?
Following the 76-day resolution process, the WIPO panel ordered the transfer of ‘rochediagnosticus.com’ to Hoffmann-La Roche Inc. The case highlights the effectiveness of UDRP proceedings in neutralizing domain-based impersonation tactics that attempt to exploit brand trust.
Facing corporate impersonation through a domain?
Protect your brand identity from deceptive sites like rochediagnosticus.com that leverage your trademark to mislead consumers. Learn how to secure your domain assets and effectively mitigate impersonation risks.
This case note is for informational purposes only and is not legal advice.
